Psychopathological Impact in Patients with History of Rheumatic Fever with or without Sydenham’s Chorea: A Multicenter Prospective Study
Alessandro Orsini(University of Pisa), Claudia Carmassi(University of Pisa), Nicolò Loddo(University of Pavia), Marianna Fabi(Azienda USL di Bologna), Alice Bonuccelli(University of Pisa), Stefania Bergamoni, Giuseppe Di Cara(University of Perugia), Marta Mosca(University of Pisa), Gabriele Simonini(Meyer Children's Hospital), Grazia Maria Giovanna Pastorino(Magna Graecia University), Nadia Assanta(Fondazione Toscana Gabriele Monasterio), Aglaia Vignoli(University of Milan), Alberto Verrotti(University of Perugia), Duccio Maria Cordelli(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Virginia Pedrinelli(Psychiatric Medical Center), Gabriele Massimetti(University of Pisa), Roberta Battini(Fondazione Stella Maris), Attilio Sica(Azienda Ospedaliera Universitaria Pisana), Salvatore Savasta(University of Cagliari), Maria Califano(University of Bologna), Chiara Baldini(Azienda Ospedaliera Universitaria Pisana), Liliana Dell’Osso(University of Pisa), Thomas Foiadelli(Policlinico San Matteo Fondazione), Niccolò Carli(University of Pisa), Edoardo Marrani(Meyer Children's Hospital), Francesca Felicia Operto(Magna Graecia University), Diego Peroni, Martina Corsi(University of Pisa), Chiara Marra(Medica (Italy)), Sofia D’Elios(University of Pisa), Anna Fetta(Istituto delle Scienze Neurologiche di Bologna), Andrea Santangelo(University of Pisa), Rita Consolini(University of Pisa), G Santangelo(Azienda di Rilievo Nazionale ed Alta Specializzazione), Pietro Marchese(University of Pisa)
International Journal of Environmental Research and Public Health
August 25, 2022
Cited by 5
Related Papers
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
|Annals of the Rheumatic Diseases|2016|355
2021 DORIS definition of remission in SLE: final recommendations from an international task force
|Lupus Science & Medicine|2021|340